What deal pacing model prevents end-of-quarter ramp-and-stall cycles?
Deal Pacing: Smooth Closes vs. Cliff Panic
Direct: Target 40-45% of quarterly close in week 1-2, 40% in week 3, 15-20% in final week. Inverted curves signal ramp-and-stall (unhealthy, forecast kills).
Operator Detail
End-of-quarter panic closing isn't strategy—it's failure signal. Healthy deals close on rhythm. Learn the curve.
The three close pacing curves:
Healthy pacing (even distribution):
- Week 1-2: 40-45% of closes (deals move continuously)
- Week 3: 35-40% of closes (mid-quarter push)
- Week 4: 15-20% of closes (final stragglers, not panic)
- Implication: Deals close predictably; forecast variance ±8-12%
- CRO story: "Our close curve is smooth; we don't cram quarter"
Ramp-and-stall (dangerous):
- Week 1-2: 15-20% of closes (early stall)
- Week 3: 25-30% of closes (some motion)
- Week 4: 55-65% of closes (panic spike)
- Signal: Reps didn't manage deals; final week becomes rescue attempt
- Forecast variance: ±25-40% (unpredictable)
- Outcome: Hit or miss by $200K+ on $1M quarterly
Backloaded curve (revenue exists but timing fragile):
- Week 1-2: 25% of closes
- Week 3: 30% of closes
- Week 4: 45% of closes (still elevated)
- Root cause: Reps won deals too late in cycle; legal/procurement hoarding
- Risk: One delayed signature = entire quarter slips
Measuring Pacing
Weekly report: % of quarterly revenue closed YTD
| Week | Healthy Target | Ramp-Stall (Bad) | Your Company | Action |
|---|---|---|---|---|
| Week 1-2 | 40-45% | 15-20% | 38% | On track |
| Week 3 | 75-85% | 40-50% | 72% | Slight behind |
| Week 4 | 100% | 95%+ at day 2 | 100% (day 3) | Recovered |
The Prevention Play
Force Management research: 87% of ramp-and-stall patterns come from reps bunching deal activity in final 10 days. Solution:
- Daily rep pacing targets (week 1 = 10% of quota close, not zero)
- Deal commitment lock (by day 5 of quarter, AE must commit signature date)
- Early legal review (legal pre-clears large deals by week 2, not week 4)
CRO Impact
Companies achieving healthy pacing add $100-300K predictability per quarter (variance reduction alone). Reps work smarter, not harder at quarter-end.
TAGS: deal-pacing,close-distribution,quarter-rhythm,deal-timing,forecast-stability,ramp-and-stall
FAQ
What does a healthy quarterly close curve look like by week? A healthy curve closes 40-45% of quarterly revenue in weeks 1-2, 35-40% in week 3, and only 15-20% in the final week as stragglers rather than panic. This even distribution produces forecast variance of just ±8-12%, which lets a CRO tell the board the team does not cram the quarter.
How do I tell ramp-and-stall apart from a backloaded curve? Ramp-and-stall closes only 15-20% in weeks 1-2 and then spikes to 55-65% in week 4, producing ±25-40% variance. A backloaded curve is milder: 25% early, 30% in week 3, and 45% in week 4 with ±15-25% variance. Ramp-and-stall signals reps never managed deals, while backloaded means revenue exists but timing is fragile.
What is the dollar risk of a ramp-and-stall quarter? With ±25-40% variance, a $1M quarter can be hit or miss by $200K or more depending on whether final-week deals land. One delayed signature in a backloaded portfolio can slip the entire quarter, since legal or procurement may be hoarding the largest deals.
What does Force Management research say causes ramp-and-stall? Force Management found 87% of ramp-and-stall patterns come from reps bunching deal activity into the final 10 days. The fix is daily rep pacing targets so week 1 closes about 10% of quota rather than zero, a deal commitment lock requiring AEs to set a signature date by day 5, and legal pre-clearing large deals by week 2.
How much value does smoothing the pacing curve actually create? Companies that achieve healthy pacing add $100-300K of predictability per quarter from variance reduction alone. The benefit is credible board reporting and reps working smarter rather than scrambling at quarter-end.